Professor Hisham Mehanna
Director, Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, University of Birmingham
About this event
- Date and time Thu 11 Mar 2021 from 2:55pm to 6:10pm
- Location Online
- Organised by Oncology, Oral and Maxillofacial Surgery
This two-part webinar series will explore the advances and current trends in the management of head and neck cancer. Hear from both national and international experts in the field provide a comprehensive and in-depth analysis of the field.
This second seminar will cover changes in the TNM classification of oral cancer and the role of immunotherapy for head and neck cancer. The benefits and alternatives to patient follow up will be explored, as well as advances in the management of osteoradionecrosis.
During this seminar, you'll be able to:
- Understand the controversies around the new TNM staging system for oral cavity cancer
- Learn about immunotherapy and recent advances
- Develop an understanding of alternative methods of follow up in head and neck cancer patients
- Explore new advances in the treatment of osteoradionecrosis
This meeting brings together an international faculty of specialists in the management of head and neck cancer and will be of great interest to all professional groups involved in managing these complex patients. Topics including surgical and oncological advances will be presented with an opportunity for a live panel discussion.
Book your place for Part 1 here >>
Registration for this webinar will close 2 hours prior to the start time. You will receive the webinar link 2 hours before the meeting. Late registrations will not be accepted.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
Join in the conversation online #RSMLive
Follow us on Twitter: @RoySocMed
Tickets
Standard pricing available until 11 March 2021.
Member
| RSM Member | RSM Trainee | RSM Student |
|---|---|---|
| £0.00 | £0.00 | £0.00 |
Non - Member
| Non - Member | Trainee | Student |
|---|---|---|
| £40.00 | £30.00 | £20.00 |
Key speakers
Professor Kevin Harrington
Professor of Biological Cancer Therapies, The Institute of Cancer Research (ICR), Consultant Clinical Oncologist, The Royal Marsden NHS Foundation
Professor Richard J Shaw
Professor of Head and Neck Surgery, Liverpool Head and Neck Centre
Dr Snehal G. Patel
Head and Neck Cancer Surgeon, Memorial Sloan Kettering Cancer Center
Agenda
View the programme here
Welcome and introduction
Professor Christopher Nutting, President Elect, Oncology Section, Royal Society of Medicine, Professor of Radiation Oncology, The Institute of Cancer Research, Director of Head and Neck Unit, The Royal Marsden NHS Foundation Trust
Current indications and results of immunotherapy
Professor Kevin Harrington, Professor of Biological Cancer Therapies, The Institute of Cancer Research (ICR), Consultant Clinical Oncologist, The Royal Marsden NHS Foundation
Is the new TNM 8 staging system a real step forward for oral cancer?
Dr Snehal G. Patel, Head and Neck Cancer Surgeon, Memorial Sloan Kettering Cancer Center
Comfort break
Are current clinical protocols for follow up of head and neck cancer patients fit for purpose?
Professor Hisham Mehanna, Director, Institute of Head and Neck Studies and Education, Institute of Cancer and Genomic Sciences, University of Birmingham
Identification and treatment of osteoradionecrosis
Professor Richard J Shaw, Professor of Head and Neck Surgery, Liverpool Head and Neck Centre
Panel discussion
Concluding remarks
Location
Online
Disclaimer: All views expressed in this webinar are of the speakers themselves and not of the RSM nor the speaker's organisations.
Special rates for difficult times
The RSM wishes to offer healthcare professionals continued learning opportunities during the coronavirus pandemic. The RSM’s weekly COVID-19 Series webinars remain free of charge, while there will be small charges to register for other online education. These fees will enable the RSM to continue its programme of activities and will apply during the course of the pandemic.
This webinar is available for on-demand viewing. The webinar recording will be available for registered delegates up to 30 days after the live webinar broadcast via Zoom. The link will be sent 24 hours after the webinar takes place.
